These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8911656)

  • 61. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
    Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distinct physiological role of amidino-TAPA-sensitive and DAMGO-insensitive μ-opioid receptor splice variants in the mouse spinal cord.
    Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Aoki Y; Kon-no T; Takagi H; Yonezawa A; Sato T; Sakurada T; Sakurada S
    Eur J Pharmacol; 2013 Jul; 711(1-3):80-6. PubMed ID: 23623932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber).
    Towett PK; Kanui TI; Juma FD
    Brain Res Bull; 2006 Dec; 71(1-3):60-8. PubMed ID: 17113929
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray.
    Tershner SA; Helmstetter FJ
    Brain Res; 2000 May; 865(1):17-26. PubMed ID: 10814729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Temporal dissociation of recovery from antinociceptive and motor effects following intrathecal administration of a selective mu-opioid agonist.
    Miaskowski C; Franck LS; Putris J; Levine JD
    Nurs Res; 1993; 42(6):344-8. PubMed ID: 8247817
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of spinal mu1-opioid receptors on the Tyr-d-Arg-Phe-sarcosine-induced antinociception.
    Mizoguchi H; Nakayama D; Watanabe H; Ito K; Sakurada W; Sawai T; Fujimura T; Sato T; Sakurada T; Sakurada S
    Eur J Pharmacol; 2006 Jul; 540(1-3):67-72. PubMed ID: 16730704
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
    Ohsawa M; Nagase H; Kamei J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):780-7. PubMed ID: 9694934
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Age-related changes in the spinal antinociceptive effects of DAGO, DPDPE and beta-endorphin in the rat.
    Crisp T; Stafinsky JL; Hoskins DL; Perni VC; Uram M; Gordon TL
    Brain Res; 1994 Apr; 643(1-2):282-6. PubMed ID: 8032922
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids.
    Campbell VC; Welch SP
    Eur J Pharmacol; 2001 Apr; 417(1-2):91-8. PubMed ID: 11301063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord.
    Przewłocki R; Costa T; Lang J; Herz A
    Eur J Pharmacol; 1987 Nov; 144(1):91-5. PubMed ID: 2830121
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats.
    Wewers ME; Dhatt RK; Snively TA; Tejwani GA
    Brain Res; 1999 Mar; 822(1-2):107-13. PubMed ID: 10082888
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.
    Aley KO; Levine JD
    J Neurosci; 1997 Oct; 17(20):8018-23. PubMed ID: 9315920
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception.
    Roerig SC
    Ann N Y Acad Sci; 2003 Dec; 1009():116-26. PubMed ID: 15028575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. G-protein antisense oligodeoxyribonucleotides and mu-opioid supraspinal antinociception.
    Raffa RB; Martinez RP; Connelly CD
    Eur J Pharmacol; 1994 Jun; 258(1-2):R5-7. PubMed ID: 7925586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The antinociceptive effect of intrathecal tramadol in rats: the role of alpha 2-adrenoceptors in the spinal cord.
    Li C; Chen SQ; Chen BX; Huang WQ; Liu KX
    J Anesth; 2012 Apr; 26(2):230-5. PubMed ID: 22038618
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat.
    Hao JX; Wiesenfeld-Hallin Z; Xu XJ
    Neurosci Lett; 1997 Feb; 223(1):49-52. PubMed ID: 9058420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse.
    Narita M; Narita M; Mizoguchi H; Tseng LF
    Eur J Pharmacol; 1995 Jul; 280(2):R1-3. PubMed ID: 7589170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evidence for the involvement of the mu but not delta opioid receptor subtype in the synergistic interaction between opioid and alpha 2 adrenergic antinociception in the rat spinal cord.
    Sullivan AF; Kalso EA; McQuay HJ; Dickenson AH
    Neurosci Lett; 1992 May; 139(1):65-8. PubMed ID: 1357605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Differences of mu-opioid receptors between Lewis and F344 rats.
    Herradón G; Morales L; Alguacil LF
    Life Sci; 2003 Aug; 73(12):1537-42. PubMed ID: 12865093
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
    Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
    Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.